[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100452385":3},{"organization":4,"armGroups":7,"interventions":54,"overallOfficials":10,"centralContacts":60,"locations":66,"responsibleParty":82,"collaborators":10,"id":84,"slug":85,"hasResults":86,"nctId":87,"briefTitle":88,"officialTitle":89,"acronym":90,"eligibilityCriteria":91,"healthyVolunteers":86,"sex":92,"minAge":93,"maxAge":10,"enrollmentInfo":94,"targetDuration":10,"studyType":97,"phases":10,"briefSummary":98,"conditions":99,"keywords":10,"overallStatus":69,"whyStopped":10,"lastUpdateSubmitDate":105,"lastUpdatePostDateStruct":106,"startDateStruct":109,"completionDateStruct":111,"leadSponsor":113,"locationsCount":114},{"fullName":5,"class":6},"Clariance","INDUSTRY",[8,14,18,22,26,30,34,38,42,46,50],{"label":9,"type":10,"description":11,"interventionNames":12},"ERISMA® LP\u002FLP EVO",null,"120 subjects with ERISMA® LP\u002FLP EVO implant",[13],"Procedure: Spine surgery",{"label":15,"type":10,"description":16,"interventionNames":17},"ERISMA® Deformity","120 subjects with ERISMA® Deformity implant",[13],{"label":19,"type":10,"description":20,"interventionNames":21},"ERISMA® MIS","120 subjects with ERISMA® MIS implant",[13],{"label":23,"type":10,"description":24,"interventionNames":25},"Idys® TLIF PEEK","50 subjects with Idys® TLIF PEEK implant",[13],{"label":27,"type":10,"description":28,"interventionNames":29},"Idys® TLIF TiVAC","50 subjects with Idys® TLIF TiVAC implant",[13],{"label":31,"type":10,"description":32,"interventionNames":33},"Idys® TLIF 3DTi","50 subjects with Idys® TLIF 3DTi implant",[13],{"label":35,"type":10,"description":36,"interventionNames":37},"Idys® ALIF PEEK","50 subjects with Idys® ALIF PEEK implant",[13],{"label":39,"type":10,"description":40,"interventionNames":41},"Idys® ALIF TiVAC","50 subjects with Idys® ALIF TiVAC implant",[13],{"label":43,"type":10,"description":44,"interventionNames":45},"Idys® ALIF 3DTi","50 subjects with Idys® ALIF 3DTi implant",[13],{"label":47,"type":10,"description":48,"interventionNames":49},"Idys® ALIF ZP 3DTi","50 subjects with Idys® ALIF ZP 3DTi implant",[13],{"label":51,"type":10,"description":52,"interventionNames":53},"Idys® LLIF 3DTi","50 subjects with Idys® LLIF 3DTi implant",[13],[55],{"type":56,"name":57,"description":58,"armGroupLabels":59,"otherNames":10},"PROCEDURE","Spine surgery","Implantation of spine Interbody Fusion Devices and\u002For Posterior fixation System.",[15,9,19,43,35,39,47,51,31,23,27],[61],{"name":62,"role":63,"phone":64,"phoneExt":10,"email":65},"Florian Laboulfie","CONTACT","+33 7 81 20 03 13","f.laboulfie@clariance-spine.com",[67],{"facility":68,"status":69,"city":70,"state":10,"zip":10,"country":71,"countryCode":72,"cosmosGeoPoint":73,"geoPoint":78,"contacts":79},"Santy Orthopedic Center","RECRUITING","Lyon","France","FR",{"type":74,"coordinates":75},"Point",[76,77],4.84789,45.74906,{"lat":77,"lon":76},[80],{"name":81,"role":63,"phone":10,"phoneExt":10,"email":10},"Henri D'ASTORG, MD",{"type":83,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100452385","clariance-erys-registry-100452385",false,"NCT05170815","Clariance ErYs Registry","Clariance Registry of ERISMA® and Idys® Devices","ErYs","Inclusion Criteria:\n\n* Considered as adult in the respective geography (18 years old or older for France and 21 years old or older for United-States).\n* Indicated for treatment with one or more commercially available sponsor spine device included into the study.\n* For France only, affiliated with or beneficiary of a social security scheme.\n\nExclusion Criteria:\n\n* Subjects who are not able to comply with the study procedures based on the judgment of the investigator (e.g., inability to comprehend study related questions, inability to keep scheduled assessment times).\n* Subjects who are considered as vulnerable: minor, pregnant woman or people under legal protection (guardianship or curatorship).\n* Contraindicated for spine surgery utilizing a commercially available sponsor spine device.","ALL","18 Years",{"count":95,"type":96},760,"ESTIMATED","OBSERVATIONAL","International, prospective, single arm, multicenter and observational Post-Market Clinical Follow-up (PMCF).\n\nThe overall objective of this study is to collect preoperative, intraoperative and postoperative (at 9 weeks, 6 months, 1 year and 2 years) data on the clinical complications and functional outcomes of the study devices to demonstrate safety and performance in a real-world setting.\n\nThe primary objective is to demonstrate that the use of the study devices is safe.\n\nThe secondary objective is to demonstrate that the use of the study devices decreases the pain, and improves the quality of life and the daily activities of the subjects.",[100,101,102,103,104],"Spine Degeneration","Spine Spondylosis Thoracic","Spinal Deformity","Spinal Tumor","Spinal Fracture","2026-03-16",{"date":107,"type":108},"2026-03-17","ACTUAL",{"date":110,"type":108},"2022-01-17",{"date":112,"type":96},"2028-12",{"name":5,"class":6},1]